Hopital Saint Louis; Dermatologie 1

Paris 75475

0 studies enrolling now · 3 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Basal Cell Carcinoma, Non-Hodgkin's Lymphoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma — Completed
• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) — Completed